US Broker Ratings

BeOne Medicines Ltd. (ONC): A Healthcare Titan with a 7.57% Potential Upside and Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, is making waves with its robust pipeline of oncology treatments and strategic partnerships. Based in..

Insulet Corporation (PODD) Stock Analysis: Riding High on Revenue Growth and Strong Buy Ratings

Insulet Corporation (NASDAQ: PODD), a leading player in the healthcare sector’s medical devices industry, has been making waves with its innovative insulin delivery systems. With a..

West Pharmaceutical Services (WST) Stock Analysis: 26% Potential Upside Awaits Investors

West Pharmaceutical Services, Inc. (NYSE: WST), a leader in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization..

Stryker Corporation (SYK) Stock Analysis: Exploring a Strong 10.42% Potential Upside

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is capturing investor attention with its robust market cap of $149.98 billion and an enticing potential..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Insights into a Potential 6.09% Upside for Healthcare Investors

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a stalwart in the global pharmaceutical industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With..

Medtronic plc (MDT) Stock Analysis: A Promising 6.17% Upside Potential in the Healthcare Sector

Medtronic plc (NYSE: MDT), a giant in the healthcare sector with a market capitalization of $119.16 billion, continues to capture investor interest with its robust portfolio..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Volatility and Growth Potential in the Healthcare Sector

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based entity specializing in Traditional Chinese Medicine (TCM), offers a unique proposition within the healthcare sector, particularly in the..

Insmed Incorporated (INSM): Investor Outlook and Potential Upside in Biotech

Insmed Incorporated (NASDAQ: INSM), a biotechnology firm focused on developing therapies for serious and rare diseases, stands out in the healthcare sector with a formidable market..

Elanco Animal Health (ELAN) Stock Analysis: Growth Potential and Market Position in the Animal Health Industry

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a formidable player in the healthcare sector, specifically within the specialized realm of drug manufacturing for both pets..

Danaher Corporation (DHR) Stock Analysis: Unlocking a 22.62% Potential Upside Amid Robust Analyst Ratings

Danaher Corporation (NYSE: DHR), a giant in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking growth and stability in..

Exact Sciences Corporation (EXAS) Stock Analysis: A 17% Upside Potential in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a prominent name in the healthcare diagnostics sector, has garnered significant attention from investors, particularly with its innovative cancer screening and..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Examining a 24.68% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a stalwart in the healthcare sector, particularly in the medical instruments and supplies industry. With a commanding market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Eyeing a 24% Upside in Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO) is a prominent name in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 10.18% Potential Upside in the Diagnostics Sector

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Venlo, the Netherlands, Qiagen specializes in transforming..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 93.92% Potential Upside in Biotechnology

Corcept Therapeutics Incorporated (NASDAQ: CORT) presents a compelling opportunity within the biotechnology sector, catering to the development of treatments for severe endocrinologic, oncologic, metabolic, and neurologic..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Diverse Portfolio with a 5.63% Upside Potential

Avantor, Inc. (NYSE: AVTR), a significant player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $9.07 billion,..

United Therapeutics Corporation (UTHR): Stock Analysis Reveals 11.87% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Exploring Growth Potential and Analyst Ratings

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to capture investor attention with its expansive portfolio in the drug manufacturing industry. With a market..

Quest Diagnostics (DGX) Stock Analysis: A Solid Healthcare Bet with Over 2% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, specifically in diagnostics and research. With a robust market capitalization of $20.52..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 31.58% Upside Amidst Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the biotechnology sector with a robust market capitalization of $8.82 billion. As an innovative leader in developing breakthrough..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds